Stockreport

Navidea drops rheumatoid arthritis programme after failed Phase III trial [Yahoo! Finance]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF The Phase III study (NCT05246280), which enrolled 523 patients, aimed to confirm the ability of intravenous (IV) Lymphoseek (Tc 99m tilmanocept) imaging to predict clin [Read more]